Eklundh, A.; Rhedin, S.; Ryd-Rinder, M.; Andersson, M.; Gantelius, J.; Gaudenzi, G.; Lindh, M.; Peltola, V.; Waris, M.; Nauclér, P.;
et al. Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study. Vaccines 2021, 9, 384.
https://doi.org/10.3390/vaccines9040384
AMA Style
Eklundh A, Rhedin S, Ryd-Rinder M, Andersson M, Gantelius J, Gaudenzi G, Lindh M, Peltola V, Waris M, Nauclér P,
et al. Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study. Vaccines. 2021; 9(4):384.
https://doi.org/10.3390/vaccines9040384
Chicago/Turabian Style
Eklundh, Annika, Samuel Rhedin, Malin Ryd-Rinder, Maria Andersson, Jesper Gantelius, Giulia Gaudenzi, Magnus Lindh, Ville Peltola, Matti Waris, Pontus Nauclér,
and et al. 2021. "Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study" Vaccines 9, no. 4: 384.
https://doi.org/10.3390/vaccines9040384
APA Style
Eklundh, A., Rhedin, S., Ryd-Rinder, M., Andersson, M., Gantelius, J., Gaudenzi, G., Lindh, M., Peltola, V., Waris, M., Nauclér, P., Mårtensson, A., & Alfvén, T.
(2021). Etiology of Clinical Community-Acquired Pneumonia in Swedish Children Aged 1–59 Months with High Pneumococcal Vaccine Coverage—The TREND Study. Vaccines, 9(4), 384.
https://doi.org/10.3390/vaccines9040384